Navigation Links
Global Insulin Antidiabetics Market 2012-2016

NEW YORK, March 7, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Global Insulin Antidiabetics Market 2012-2016

TechNavio's analysts forecast the Global Insulin Antidiabetics Market 2012-2016 to grow at a CAGR of 12.25 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in diabetic population. The Global Insulin Antidiabetics market has also been witnessing the trend of an increase in awareness and education. However, the increase in use of complementary and alternative medicine could pose a challenge to the growth of this market.

TechNavio's report, the Global Insulin Antidiabetics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Global Insulin Antidiabetics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Novo Nordisk A/S, Sanofi S.A, and Eli Lilly and Co.

Key questions answered in this report:

What will the market size be in 2016 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? You can request one free hour of analyst time when you purchase this report. Details provided within the report.

TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.

Methodology Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

01. Executive Summary 02. Introduction 03. Market Coverage Market Overview Key Offerings 04. Market Landscape Market Size and Forecast 04.1 Patent Expiry Dates for Major Antidiabetics 04.2 Five Forces Analysis 05. Geographical Segmentation 06. Rate of Incidence and Prevalence 07. Vendor Landscape 08. Buying Criteria 09. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Key Vendor Analysis 14.1 Novo Nordisk A/S Business Overview Key Information SWOT Analysis 14.2 Sanofi S.A. Business Overview Key Information SWOT Analysis 14.3 Eli Lilly and Co. Business Overview Key Information SWOT Analysis 15. Other Reports in this Series

List of Exhibits: Exhibit 1: Global Insulin Antidiabetics Market 2012-2016 (US$ billion)

Exhibit 2: Global Insulin Antidiabetics Market Segmentation

Exhibit 3: Global Insulin Antidiabetics Market Segmentation 2012

Exhibit 4: Global Insulin Antidiabetics Market by Geographical Segmentation 2012

Exhibit 5: Global Insulin Antidiabetics Market by Vendor Segmentation 2012

To order this report:Drug_and_Medication Industry: Global Insulin Antidiabetics Market 2012-2016

Contact Clare:
US:(339) 368 6001
Intl:+1 339 368 6001


SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization
2. For International Life Sciences, Biotech and Pharmaceutical Events, Top Executives Turn to Global Information
3. HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be Webcast
4. Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
5. Global Gynecological Devices Market is Expected to Reach USD 5.3 Billion by 2018: Transparency Market Research
6. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
7. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
8. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
9. Henry Schein to Present at the 2013 Barclays Global Healthcare Conference
10. Sequenom Announces Participation At The Barclays Global Healthcare Conference
11. Evofem Announces Strategic Alliance with WomanCare Global
Post Your Comments:
(Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
(Date:11/25/2015)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer of ... Antonius Schuh, Ph.D., is scheduled to present a corporate ... Healthcare Conference. th Annual Piper Jaffray ... New York on Tuesday, December ... be available for one-on-one meetings during the conference. The ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 ... global pharmaceutical company, and Rugen Therapeutics, a start-up ... treatments for unmet CNS disorders and funded by ... that they have entered into an exclusive collaboration ... therapies for Autism Spectrum Disorders (ASD) and Obsessive ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens ... Disorder, Bruxism, and moderate facial wrinkling. While many patients are aware of the benefits ... great success Botox® delivers to those suffering with discomfort, soreness, and pain as a ...
(Date:11/25/2015)... Evanston, IL (PRWEB) , ... November 25, 2015 ... ... homage to six decades of music, friendships, and learning in its 65th Anniversary ... be held Dec. 5-6. , For 65 years, Brillianteen has been ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving (MADD) ... below 10,000 for the first time since 2011. In 2014, there were 9,967 fatalities ... released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in ...
(Date:11/25/2015)... ... November 25, 2015 , ... "When I underwent ... bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order to ... the patent-pending RECOVERY BRA for added comfort and support. The bra is easier ...
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also known ... people who find their cholesterol levels and weight are creeping up are more likely ... don’t have any of the other symptoms. , Thyroid hormone plays a major role ...
Breaking Medicine News(10 mins):